Invention Grant
- Patent Title: Cell-permeable (CP)-Cas9 recombinant protein and uses thereof
-
Application No.: US16337250Application Date: 2017-09-27
-
Publication No.: US11319546B2Publication Date: 2022-05-03
- Inventor: Daewoong Jo
- Applicant: CELLIVERY THERAPEUTICS, INC.
- Applicant Address: KR Seoul
- Assignee: CELLIVERY THERAPEUTICS, INC.
- Current Assignee: CELLIVERY THERAPEUTICS, INC.
- Current Assignee Address: KR Seoul
- Agency: Sughrue Mion, PLLC
- International Application: PCT/KR2017/010747 WO 20170927
- International Announcement: WO2018/062866 WO 20180405
- Main IPC: C12N9/22
- IPC: C12N9/22 ; C12N15/82 ; C07K19/00
Abstract:
The present invention relates to providing cell-permeable (CP)-Cas9 recombinant protein and uses thereof. Preferably, the CP-Cas9 recombinant protein may be used as Cas9 nuclease for CRISPR/Cas9 system by utilizing the platform technology for macromolecule intracellular transduction.
Public/Granted literature
- US20190233835A1 CELL-PERMEABLE (CP)-CAS9 RECOMBINANT PROTEIN AND USES THEREOF Public/Granted day:2019-08-01
Information query
